06421nam a22005655i 4500001001800000003000900018005001700027007001500044008004100059020003700100024003500137050001600172050001400188072001700202072002300219072001600242245018300258250001800441264007200459300004400531336002600575337002600601338003600627347002400663505296600687520136903653650003105022650003005053650002705083650002305110650003005133650002105163650003205184650002605216650002305242650003005265650002505295700009105320700010105411700008405512710003405596773002605630776003605656776003605692776003605728856004605764912001405810912001405824999001705838978-981-99-5696-8DE-He21320251030111451.0cr nn 008mamaa240228s2024    si |    s    |||| 0|eng d  a97898199569689978-981-99-5696-87 a10.1007/978-981-99-5696-82doi 4aR850.A1-854 4aQH315-320 7aMBGR2bicssc 7aMED1060002bisacsh 7aMBGR2thema10aFungi Bioactive Metabolitesh[electronic resource] :bIntegration of Pharmaceutical Applications /cedited by Sunil Kumar Deshmukh, Jacqueline Aparecida Takahashi, Sanjai Saxena.  a1st ed. 2024. 1aSingapore :bSpringer Nature Singapore :bImprint: Springer,c2024.  aXVII, 762 p. 1 illus.bonline resource.  atextbtxt2rdacontent  acomputerbc2rdamedia  aonline resourcebcr2rdacarrier  atext filebPDF2rda0 aPart I: Bioactive Compounds from Endophytic Fungi -- Chapter 1. Recent Advances in Pharmaceutically Important Compounds from Endophytic Fungi -- Chapter 2. Pharmaceutically Important Compound Produced by Endophytic Fungi Having Anti-Infective Activity -- Chapter 3. Fungal Endophytes: An Accessible Natural Repository for Discovery of Bioactive Compounds -- Part II: Endolichenic Fungi: A Source of New Chemical Entities -- Chapter 4. Endolichenic Fungi as a Source of Pharmaceutically Active Compounds -- Chapter 5. Endolichenic Fungi, an Emerging Source of Bioactive Compounds: A Pharmaceutical Perspective -- Part III: Marine Fungi as a Source of Medicinal Compounds -- Chapter 6. Antibiofilm Metabolites from Sponge-derived Aspergillus, Penicillium, and Fusarium for the Antibiotic Pipeline -- Chapter 7. Marine Fungi as a Bioresource of Medicinal Entities -- Chapter 8. Natural Bioactive Products from Marine Fungi against Bacterial Infection. Part IV: Fungi as a Bioresource of Pharmacologically Active Agents -- Chapter 9. Penicillium: A Treasure-Trove for Antimycobacterial and Antioxidant Metabolites -- Chapter 10. Metabolites from Fungi: a Promising Source of Lead Compounds against Cancer -- Chapter 11. Edible Mushrooms Substances as Natural Prevention in Autoimmunological Diseases -- Chapter 12. New Antifungal Drugs: Discovery and Therapeutic Potential -- Chapter 13. Fungal Enzyme Inhibitors: Potent Repository of Lead Compounds to Curb Cancer -- Chapter 14. Bioactive Metabolites from Fungi with Anti-Inflammatory and Anti-Thrombotic Properties; Current Status and Future Perspectives for Drug Development -- Chapter 15. Progress in the Development of Fungal Metabolites as New Drugs for Human Mycoses -- Part V: Fungi from Extremophilic Environment/Unique Ecosystems -- Chapter 16. Uncovering the Desert Fungal Enigma: An Attractive Resource for Biopharmaceuticals -- Chapter 17. Bioactive Metabolites Produced by Fungi Present inAntarctic, Arctic and Alpine Ecosystems -- Part VI: Novel Strategies to Screen or Enhance Secondary Metabolite Production -- Chapter 18. Enhancing Chemical Diversity of Fungal Secondary Metabolite by OSMAC Strategy -- Chapter 19. Epigenetic Regulation of Fungal Secondary Metabolites for the Enhancement of Therapeutically Active Compounds -- Chapter 20. Strategies for Enhancing the Production of Echinocandin -- Part VII: Other by Products of Fungal Metabolism with Medicinal Applications -- Chapter 21. Fungal Pigments: Applications and Their Medicinal Potential -- Chapter 22. A Brief Insight into Peptide and Non-Peptide Drugs of Fungal Origin -- Chapter 23. Kojic Acid from Aspergillus wentii: A Journey from Isolation to Application -- Part VIII: Bioinformatics and Fungal Biotransformations in Pharmaceutical Drug Development -- Chapter 24. How Does Bioinformatics Play a Role in Fungal Drug Discovery? -- Chapter 25. Fungal Biotransformation of Steroids: History, Current Status, and Future Prospects. .  aThis book presents the exploration and exploitation of various bioactive metabolites obtained from fungi isolated from diverse habitats for pharmaceutical applications. Various fungal sources have been brought under one umbrella ranging from endophytes, marine fungi, endolichenic fungi to fungi existing in the extremophilic conditions like desert and Antarctica and Artic environment. The book tries to cover maximally the range of the pharmaceutical applications wherein these bioactive agents from fungi have been exploited or are in the clinical pipelines and primarily include antibacterial, antifungal, antibiofilm, anticancer, antioxidant, autoimmunological, anti-inflammatory, and anti-thrombotic diseases. The book further emphasizes on the novel strategies to screen or enhance secondary metabolite production. Some other topics includes peptides, nonpeptides drugs, pigments, and enhancement of production of Echinocandin and Kojic acid. The role of bioinformatics in drug discovery and biotransformations have also been discussed. This book is going to be a comprehensive treatise and a valuable source for mycologists, biotechnologists, microbiologists, biotechnologists, and undertaking research in pharmaceutical sector as well as academia in setting up their research aspirations for using fungi in the process of drug discovery and development. . 0aMedicinexResearch.962598 0aBiologyxResearch.965629 0aDrug delivery systems. 0aMolecular biology. 0aMolecular ecology.972017 0aCytology.96743614aBiomedical Research.96563324aDrug Delivery.96942924aMolecular Biology.24aMolecular Ecology.97201824aCell Biology.9674401 aDeshmukh, Sunil Kumar.eeditor.4edt4http://id.loc.gov/vocabulary/relators/edt9720191 aTakahashi, Jacqueline Aparecida.eeditor.4edt4http://id.loc.gov/vocabulary/relators/edt9720201 aSaxena, Sanjai.eeditor.4edt4http://id.loc.gov/vocabulary/relators/edt9720212 aSpringerLink (Online service)0 tSpringer Nature eBook08iPrinted edition:z978981995695108iPrinted edition:z978981995697508iPrinted edition:z978981995698240uhttps://doi.org/10.1007/978-981-99-5696-8  aZDB-2-SBL  aZDB-2-SXB  c57975d57975